Trial Summary
What is the purpose of this trial?The goal of this clinical trial is to identify the recommended financial reimbursement amount for women with breast cancer enrolled in a clinical trial. The main questions it aims to answer are:
1. What is the recommended financial reimbursement amount in trial-enrolled women with breast cancer experiencing financial toxicity?
2. What do patients think about receiving a reimbursement for trial-incurred expenses?
Participants will receive a monthly reimbursement to compensate for their trial-incurred expenses in cohorts, which will de-escalate for the next participant cohort if patients find the reimbursement dose suitable (negative financial toxicity screen, reimbursement dose deemed acceptable/appropriate). Researchers will also use qualitative interviews to explore patient perceptions of the trial reimbursements.
Eligibility Criteria
This trial is for women with breast cancer who are already part of the I-SPY TRIAL 2 at UAB Medical Oncology Clinic. It's not open to men, non-English speakers, or female patients not enrolled in I-SPY TRIAL 2.Inclusion Criteria
I am a woman with breast cancer participating in the I-SPY TRIAL 2 at UAB.
Exclusion Criteria
Non-English speakers
I am a female cancer patient not participating in the I-SPY TRIAL 2.
I am a female and I do not have cancer.
+1 more
Participant Groups
The study is testing different amounts of money given back to participants to cover costs related to being in a clinical trial. The goal is to find out what amount feels right and helps reduce financial stress from these expenses.
1Treatment groups
Experimental Treatment
Group I: Patients receiving reimbursementExperimental Treatment1 Intervention
Monthly reimbursement to offset trial-related expenses
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of Alabama at BirminghamBirmingham, AL
Loading ...
Who Is Running the Clinical Trial?
University of Alabama at BirminghamLead Sponsor